Protect Your Patients—Secure Your Practice with PtProtect®

Opioid analgesics have a legitimate and important role in managing chronic pain. Yet the use and abuse of prescription medications is a growing problem throughout the United States.

An accurate determination of a patient’s medication intake is critical to patient safety. Our statistics suggest a 6-in-10 chance that a patient’s urine drug test result will disclose information not explained by the patient’s known pain medication prescriptions.

With PtProtect, you get the confidence and reliability you need to ensure successful pain medication monitoring:

Comprehensive

Detects up to 38 prescribed medications and illicit drugs, reducing the possibility of adverse drug reactions and identifying potential diversion of medications.

Sensitive

Uses Liquid Chromatography/Tandem Mass Spectrometry (LC/MS/MS) and the lowest available detection thresholds for the most accurate and sensitive opiate/opioid testing. Our data shows that up to 30 percent of drugs found by LC/MS/MS would have been missed using conventional immunoassay screens for opiates and opioids.

Interpretive

Analytical reports and easy-to-understand interpretive comments eliminate guesswork and save you time.

The PtProtect difference:

• Board-certified toxicologists are available for consultation from test selection to result interpretation.
• Opiate screens used by other laboratories only detect codeine and morphine, not other opioid analgesics, without relying on an initial screen.
• Uses lowest detection thresholds for most sensitive, comprehensive detection of opiates and opioids.
• Heroin metabolite (6-monoacetylmorphine) testing available on most panels

Download the PtProtect Physician Update for information:

PtProtect Pain Medication Management Program.pdf​